Newbridge Financial Services Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Newbridge Financial Services Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,650	Closed	-$2.39K	–	1473
2023 Q1	$2.39K	Hold	6,650	–	–	﹤0.01%	1174
2022 Q4	$5.89K	Hold	6,650	–	–	﹤0.01%	1032
2022 Q3	$10K	Hold	6,650	–	–	0.01%	898
2022 Q2	$13K	Hold	6,650	–	–	0.01%	795
2022 Q1	$15K	Sell	6,650 -750	-10%	-$2.34K	0.01%	823
2021 Q4	$34K	Sell	7,400 -12,925	-64%	-$80.2K	0.02%	579
2021 Q3	$155K	Buy	20,325 +2,275	+13%	+$19.3K	0.1%	203
2021 Q2	$175K	Buy	18,050 +1,000	+6%	+$7.96K	0.11%	195
2021 Q1	$141K	Sell	17,050 -5,500	-24%	-$58.1K	0.1%	207
2020 Q4	$154K	Sell	22,550 -4,350	-16%	-$34.9K	0.13%	169
2020 Q3	$300K	Buy	+26,900	New	+$246K	0.3%	75

Other funds holding SRNE

SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return

KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return

Russell Investments Group

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return